Author Archives: Paul Goulding

When is a Biomarker not a biomarker? (part 2)

Progenesis prevents scientists reaching conclusions that are the direct opposite of the reality: part 2

When is a Biomarker not a biomarker? (part 1)

How Progenesis QI leads to the correct statistical conclusion.

Report research with confidence – Who else wants to publish small molecule LC-MS analysis confidently?

800+ groups worldwide publish LC-MS research findings with confidence using Progenesis’ unique co-detection. Read about 2 recent publications.

Missing values: the Progenesis co-detection solution

Explanation of how Progenesis QI uniquely provides an Omics data analysis with no missing values, giving a robust statistical analysis.

Missing values: what’s the problem?

What are missing values and why are they a problem in LC-MS based ‘omics analysis?

Big cities and big science in Asia

Hi, my name’s Paul Goulding and I’m Nonlinear’s Business Development Manager for Asia, Africa and Australasia. I’ve been involved with sales to Asia and the Asia-Pacific region for many years now and have travelled to countries such as Japan, China, India, South Korea and Australia many times. This has given me the privilege of visiting […]

A round up from HUPO 2010

It’s been great to be back here in beautiful Sydney for HUPO 2010! Though I’ve been here a few times before, it’s my first experience of an Australian winter (it’s a bit like a British summer). Though I understand the delegate numbers are maybe a little down on previous years, an impressive number of delegates […]